Showing results (681-690 of 1,243) with videos related to

Sort By:
Pageof 125
Pharmaceutical Statistics|August 26, 2017
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudyDouglas F Arbetter, Purva Jain, Megan K Yee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 31, 2008
Infectious complications in extended criteria heart transplantationKeshava Rajagopal, Brian Lima, Rebecca P Petersen, et al.
JACC. Heart Failure|August 13, 2013
Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)Jonathan P Piccini, Anne S Hellkamp, David J Whellan, et al.
The American Journal of Cardiology|July 16, 2013
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgeryJonathan P Piccini, Yue Zhao, Benjamin A Steinberg, et al.
BMJ Open|August 9, 2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trialDagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, et al.
European Journal of Heart Failure|January 28, 2014
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF TrialMustafa Toma, Justin A Ezekowitz, Jeffrey A Bakal, et al.
Biomolecules|April 3, 2021
Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 DiabetesOscar Alcazar, Luis F Hernandez, Ernesto S Nakayasu, et al.
American Heart Journal|May 24, 2025
Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trialVeraprapas Kittipibul, Derek D Cyr, Josephine Harrington, et al.
Journal of Thrombosis and Thrombolysis|December 24, 2022
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX TrialGerald Chi, Francesco Violi, Pasquale Pignatelli, et al.
Intensive Care Medicine|February 20, 2019
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudyGerald Chi, C Michael Gibson, Arzu Kalayci, et al.
Pageof 125